TP53 and cancer: Conversely, the SMBO-109 organoid line had clonal mutations in both TP53 and RB1 (both with 100% cancer cell fraction (ccf)) in addition to homogenous copy number at the respective gene loci suggesting that these alterations arose early during disease pathogenesis.